Prospective Evaluation of the Clinical and Economic Outcomes of Total Joint Replacement: The HSS Shoulder Arthroplasty Cohort
IRB Number: 26117
inactiveOctober 05, 2007
Institutional Review Board, Hospital for Special Surgery
The safety of our participants is our top priority. The trial/study is approved and periodically reviewed by the Institutional Review Board (IRB), which includes doctors, administrators, ethicists, and members of the general public. The safety of clinical trials is reviewed by the U.S. Food and Drug Administration.
Before enrolling in a clinical trial or research study, the investigator will explain the purpose of the trial/study, its expected benefits, any possible risks or side effects, and what your role will be. If you want to join the trial/study, you must sign informed consent documents. You can leave a trial/study at any time without penalty.
For further information, see Understanding Clinical Trials/Research Studies.
Principal Investigator
Co-Investigators
- Answorth A. Allen, MD
- David W. Altchek, MD
- Kenneth Chambers, MD
- Struan H. Coleman, MD, PhD
- Frank A. Cordasco, MD, MS
- Edward V. Craig, MD, MPH
- Brian de Palma
- Demetrios Delos, MD
- David M. Dines, MD
- Joshua S. Dines, MD
- Kevin DiSilvestro
- Stephen Fealy, MD
- Mark P. Figgie, MD
- Steven R. Goldring, MD
- Jo A. Hannafin, MD, PhD
- Kristofer Jones, MD
- Richard Kang, MD
- Heather Kawalick
- EmilyYing Lai
- Yuo-yu (Lily) Lee
- Stephen Lyman, PhD
- John D. MacGillivray, MD
- Gregory Mahony
- Lisa A. Mandl, MD, MPH
- Andrew Merritt, MD
- Danyal H. Nawabi, MD, FRCS
- Stephen J. O'Brien, MD, MBA
- Delia Pais
- Scott A. Rodeo, MD
- Howard Anthony Rose, MD
- Beth E. Shubin Stein, MD
- Russell F. Warren, MD
- Thomas L. Wickiewicz, MD
- Riley J. Williams III, MD
Summary
We will enroll all TSA patients who undergo surgery at HSS and consent to be in the study. We estimate this to be approximately 200 patients a year. Patients will receive follow-up questionnaires at one year, two years and five years after their surgery.
Inclusion/Exclusion Criteria
Patients 18 years or older undergoing total shoulder arthroplasty at HSS
Contact Information
Principal Investigator
Lawrence Gulotta, MD
646.797.8735
Research Coordinator
Gregory Mahony
212.774.2449